You are here

Article info

Article menu

Download PDFPDF

Liver
Guideline review
Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)

Authors

  • Paul N Brennan Centre for Regenerative Medicine, The University of Edinburgh Edinburgh Medical School, Edinburgh, UK Molecular and Clinical Medicine, University of Dundee School of Medicine, Dundee, UK PubMed articlesGoogle scholar articles
  • Peter Cartlidge Department of Gastroenterology, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK PubMed articlesGoogle scholar articles
  • Thomas Manship Centre for Liver and Digestive Disorders, NHS Lothian, Edinburgh, UK PubMed articlesGoogle scholar articles
  • John F Dillon Department of Gastroenterology, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK Molecular and Clinical Medicine, University of Dundee College of Medicine Dentistry and Nursing, Dundee, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Paul N Brennan, Centre for Regenerative Medicine, The University of Edinburgh Edinburgh Medical School, Edinburgh EH8 9YL, UK; p.z.brennan{at}dundee.ac.uk
View Full Text

Citation

Brennan PN, Cartlidge P, Manship T, et al
Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
Frontline Gastroenterology 2022;13:332-336.

Publication history

  • Received April 16, 2021
  • Accepted July 19, 2021
  • First published July 29, 2021.
Online issue publication 
July 13, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.